Corpus Intelligence IC Memo — ALLIANCEHEALTH DURANT 2026-04-26 05:27 UTC
IC Memo — ALLIANCEHEALTH DURANT
Investment Committee Memorandum | OK | 105 beds | Grade C | EBITDA uplift $8.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ALLIANCEHEALTH DURANT

CCN 370014 | BRYAN, OK | 105 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ALLIANCEHEALTH DURANT is a 105-bed suburban community hospital in BRYAN, OK with $113.7M in net patient revenue and a 24.4% operating margin. The hospital serves a payer mix of 40.1% Medicare, 27.4% Medicaid, and 32.5% commercial.

Thesis: Turnaround. Our ML models identify $8.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 24.4% to 31.8% (+736bps).

Net Revenue HCRIS$113.7M
Current EBITDA COMPUTED$27.8M
Operating Margin COMPUTED24.4%
Occupancy HCRIS57.4%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS8.7%
Distress Probability ML50.6%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
39
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 24.4% places it above the state median. Among 39 size-comparable peers (52-210 beds), the median margin is -3.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-210), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ALLIANCEHEALTH DURANT (Target)OK105$113.7M24.4%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
COMANCHE COUNTY MEMORIAL HOSPIOK201$304.2M-7.9%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$73K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$73K
Total EBITDA Uplift$8.4M
Current EBITDA$27.8M
+ RCM Uplift+$8.4M
Pro Forma EBITDA$36.1M
Current Margin24.4%
Pro Forma Margin31.8%
WC Released (1x)$4.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$42.7M$266.9M6.24x44.2%
Base (11x exit)10.0x11.0x$42.7M$307.5M7.19x48.4%
Bull Case9.0x11.0x$38.5M$349.0M9.07x55.4%
Bull (12x exit)9.0x12.0x$38.5M$392.1M10.19x59.1%
Bear Case11.0x10.0x$47.0M$211.2M4.49x35.0%
Bear (11x exit)11.0x11.0x$47.0M$247.6M5.27x39.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (27.4%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 52-210 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-16.0% / P50=-3.3% / P75=6.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.